Introduction
The Thy-I gene is a member of the immunoglobulin superfamily of genes and codes for a 112 amino acid surface glycoprotein that is anchored on the membrane through a phospholipid tail (Williams and Gagnon, 1982; Low and Kincade, 1985; Tse et al., 1985) . Certain members of the family are expressed in both the immune and the nervous system (e.g. Thy-i, OX2, CD4) or solely in the nervous system of several eukaryotes (e.g. LI, N-CAM, fasciclin-II, MAG, PO, amalgam) (Dodd and Jessel, 1988; Harrelson and Goodman, 1988; Williams and Barclay, 1988) . It was, therefore, proposed that the immune system is evolutionarily related to the nervous system and that Thy-I possibly represents the primordial domain of the immunoglobulin superfamily (Williams and Gagnon, 1982) .
The Thy-i gene is expressed in a wide variety of tissues during development and the pattern varies considerably between species (for review see Morris, 1985; Cooper and Mansour, 1989) . Typically, it appears in mammals on the surface of all neurons except those of the olfactory mucosa (Morris, 1985) . Expression in the nervous system is under tight developmental control and represents a terminal differentiation marker (Morris and Grosveld, 1989) .
The mouse protein is also expressed in thymocytes (Reif and Allen, 1963) , peripheral T cells and, to a lesser extent, in several other tissues (e.g. muscle), but it is not present in kidney. In contrast, human Thy-I appears in adult human spleen and kidney epithelium but is absent from thymocytes and T cells (McKenzie and Fabre, 1981) .
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The function of the protein remains to be determined, but its conserved pattern of expression in the nervous system of most species implies a possible role in cell -cell recognition and interaction during morphogenesis (Cohen et al., 1981) .
By virtue of its developmental expression in certain tissues, Thy-I represents an excellent system to study mechanisms that underlie tissue-specific regulation of genes.
The promoter of the Thy-i gene (Spanopoulou et al., 1988 ) is located in a CpG-rich island (Bird, 1986 ) and lacks a TATA box which is characteristic of housekeeping gene promoters (Dynan, 1986) . Initiation of transcription occurs from multiple sites and, interestingly, the distribution of these sites is different in murine brain and thymus (Spanopoulou et al., 1988) . Previous studies from several laboratories (Chen et al., 1987; Gordon et al., 1987; Kollias et al., 1987a,b) have shown that an 8.2 kb fragment containing the human or murine gene contained sufficient sequences to direct expression of the gene(s) to the appropriate tissues in transgenic mice with the exception of peripheral T cells. Taken together with the presence of a number of DNase I hypersensitive sites downstream from the promoter (Spanopoulou et al., 1988) , these data indicated that at least some regulatory regions might be situated within the body of the gene. A number of hybrid and deletion constructs were generated to identify the sequences that dictate tissue specificity in the Thy-i transcriptional unit. These were analysed in transgenic mice to allow the study of the developmental regulation of the transgenes in several tissues. In this paper we describe the localization of several of the elements in the mouse and human genes that are responsible nAn ri r--, mh (E lorris, 1985) , with the excepThy-I genes in transgenic mice (Gordon et al., 1987 for RNA analysis by deleting a 300 bp fragment from the untranslated region of the last exon (Chen et al., 1987) . A 360 bp SphI-AvaIl probe (derived from the wild-type fragment and cloned in pUC 18), was labelled at the 5' end (Avall site), thus protecting both the endogenous and a shorter fragment for the exogenous transcripts (360 and 160 bp, respectively). RNA from transgenic lines: h, mh and hmh was hybridized to a 3' labelled NcoI-BgllI 950 bp human probe which detects the poly(A) sites of the foreign mRNA (protected fragments: 165 and 390 bp). The presence of two poly(A) sites in the human gene has been reported previously (Kollias et al., 1987a) . mhm transcripts were assayed with a 3' labelled BstEII-ApaI 980 bp human probe detecting the splicing junction between exon 3 -intron 3 (protected fragment: 320 bp). Endogenous mouse Thy-I mRNA was detected by a 5' end-labelled Sac-TthlllI 680 bp fragment which protects part of the fourth exon (protected fragment: 244 bp) except in (Foon et al., 1984 (Spanopoulou et al., 1989 from the murine H2-Kb gene (Kimura et al., 1986) . In NF-L-Thyl, a 2.5 kb fragment containing 5' flanking and promoter sequences of the human neurofilament light chain gene (NF-L), was inserted in the first exon of the mh hybrid. In IVS3 -Hj3, the third intron of the mouse Thy-i gene was cloned upstream of the human f3-globin (-700).
Finally, OMP-Thy-1 hybrid represents the rat OMP gene in which coding sequences were replaced by exon 3-intron 3 and part of exon 4 of the mouse Thy-I gene (Danciger et al., 1989) . The (*) indicates expression of the transgene in the olfactory nerve (lane B). As in Figure 1 , we analysed brain (B), thymus (T), kidney (K), liver (L) and spleen (S). Non-determined (nd).
Murine Thy-1 brain expression
To verify a previous observation (Chen et al., 1987) (Kimura et al., 1986) or human neurofilament light chain (NF-L) promoters (Julien et al., 1987) , respectively (see Figure 3) . RNA was prepared from brain (B), thymus (T), liver (L), spleen (S) and heart (H), and assayed for transcripts by SI protection analysis. Probes specific for the endogenous (en) and transgenic (Thyl) of the H2-Thyl construct are described in Figure 2 . SI analysis of NF-L-Thyl lines detects only transgenic transcripts with a 620 bp BssHI-Hinfl probe (a fragment derived from the NF-L-Thyl construct) specific for initiation of transcription (112 bp protected fragment). r.t. are read-through transcripts. NF-L-Thyl line 1550 is an established line and therefore heterogeneity in expression cannot be due to mosaicism.
the possibility that the element may at least in part be within intron 2, we also tested a larger 2.1 kb PstI fragment which includes exon 2-intron 2 sequences. However, this construct also failed to express in the brain, in four transgenic lines tested (data not shown). To investigate whether the brain specific sequences would be functional if placed further downstream, we inserted a 4.8 kb fragment from a constitutively expressed gene (c-myc) into the NruI site of the first intron of Thy-I (Thy 1 -myc). This construct which leaves out the myc first exon and attenuation sequences (Bentley and Groudine, 1986; Nepveu and Marcu, 1986) results in high expression in the thymus where it causes large thymomas by -2 months of age (Spanopoulou et al., 1989) . However, it fails to express in the brain (Figure 5 ), even though the c-myc was placed within the part of the intron not required for expression (see above Ai /2IVS 1, Figures  1 and 4) . This suggests that the brain specific regulation may take place at the level of RNA stabilization and we therefore carried out transcriptional run-on analysis with the constructs Thyl -myc or PN-A1VS1,2. The results (Figure 5, bottom) showed that, with both constructs, transcriptional activity in brain and thymus was in agreement with the steady state levels of RNA as detected by SI analysis and RNase protection ( Figure 5 , top panels). This suggests that the lack of expression in brain by the interruption or deletion of intron 1 is not due to RNA instability, but to the loss of a transcription element.
To test whether brain-specific sequences could be functional in their natural context, the Thy-I promoter sequences were replaced by heterologous promoters, maintaining the body of the Thy-i gene intact. In the first construct, 2.5 kb fragment of the neurofilament light chain gene promoter was used to drive expression of Thy-I (NF-L-Thyi, Figure 3) ; in the second, the Thy-I promoter was substituted with a minimal promoter (-100 bp) from the MHC class I H2-K gene (Kimura et al., 1986 ) (H2 -Thy 1, Figure 3 ). Both constructs expressed at high levels in the brain (Figure 6 ). Moreover, when the NF-L-Thyl lines were analysed for expression in brain of neonate animals, no transgenic transcripts were detected, thus mimicking the developmental expression pattern of the Thy-i gene (Kollias et al., 1987a) rather than that of the neurofilament gene which is activated much earlier (Julien et al., 1987; K.Yazdanbakhsh and M.Vidal, unpublished) . We therefore conclude that the Thy-I first intron contains at least part of an element which enhances nerve cell specific expression of heterologous promoters in a tissue and developmental specific manner, but that this element is only active in a particular context or position.
Thymic expression of the mouse Thy-1 gene is dependent on intronic sequences During the analysis of mhm and hmh transgenes, the murine third intron emerged as a strong candidate for a cis-acting element in the thymic environment (see Figure 2 ). This was confirmed by deletion of intron 3 (AIVS3, Figures 3 and  4) . Four transgenic lines were analysed and found to be negative for expression of the transgene in the thymus in contrast to simultaneous high levels of expression in the brain (Figure 4) . Thus, intron 3 might be a 'classical' enhancer element or, altematively, a cis-acting element affecting Thy-I expression only when located in its natural context. We therefore tested if intron 3 could direct the expression of heterologous promoters to the thymus and if it was independent of its position in the transcriptional unit. Three heterologous promoters were tested in three different transgenic line series, i.e. the NF-L-Thyl and H2-Thyl hybrids (see above), as well as an olfactory marker protein (OMP)-Thyl fusion gene (Figure 3 ). All three different transgenes were highly expressed in the thymus demonstrating the ability of Thy-I thymic specific sequences to activate heterologous promoters in the thymus (Figure 6 ).
These sequences were also able to activate early thymic expression of the Thy 1 -myc fusion construct, even when placed 5.0 kb further downstream to the Thy-l promoter ( Figure 5 , SI and run-off analysis). To test whether intron 3 could activate transcription of heterologous promoters autonomously (like 'classical' enhancers), IVS3 was cloned in front of the human F3-globin gene (IVS3 -Hf3 construct, Figure 3 ). With the exception of line 1864, all mice showed human f-globin transcripts in the thymus at levels at least as high as seen in spleen ( Figures 3 and 6) ; the comparison of the levels of endogenous ,B-globin found in brain and thymus exclude that transgenic globin transcripts in thymus came from contaminating blood. We therefore conclude that expression of the murine Thy-I gene in thymus is controlled by an element in the third intron with the properties of a classical enhancer.
Discussion
Independent regulatory elements control Thy-1 in multiple tissues We have used transgenic mice as an expression system to study the control elements of Thy-i, a gene expressed in a tissue-specific and developmentally controlled manner. This approach has a number of advantages over tissue culture cell systems; firstly, it overcomes the problem of the lack of particular suitable cell lines (e.g. neurons); secondly, expression data for different tissues are comparable in terms of gene dosage and integration site; thirdly, it allows proper developmental studies. Using such an approach, several regulatory elements have been mapped (Figure 7) within the 8.2 kb EcoRI fragment containing the Thy-I transcriptional unit. We have found that Thy-I thymus expression is controlled by sequences located in intron 3 of the murine gene, whereas the equivalent region in the human gene controls expression of Thy-I in tubular epithelia of the kidney. Although Thy-I is not expressed in vivo in human kidney glomeruli, a second kidney specific element is located at the 3' end of the human gene. This element is only active in the presence of the third exon/intron sequences of the murine gene and causes ectopic expression in kidney glomeruli. Another sequence in the first and second intron region of the human Thy-I gene appears to be involved in spleen specific expression. Lastly, a region at the 3' end of intron I is required for expression in brain. All these elements appear to act separately because expression in different tissues can be affected independently (Figures I  and 2 ). For example, deletion of introns 1 and 2 abolish brain expression with no effect on thymus expression and, conversely, deletion of intron 3 allows the gene to be expressed in brain but not in thymus. The fact that multiple regulatory elements work independently of each other has also been observed for other 'single' promoter genes,e.g. Drosophila, ypl (Garabedian et al., 1985) , Fushi tarazu (Ftz) (Hiromi et al., 1985) or Ultrabithorax (Ubx) (Bienz et al., 1988) , and human apolipropotein Al (Sastry et al., 1988) , rat PEPCK (Benvenisty et al., 1989) or the extensively characterized chicken lysozyme gene (Sippel and Renkawitz, 1989) . This type of regulation must be present in many genes and perhaps even ubiquitously expressed (housekeeping) genes are regulated by a number of different enhancer elements. Cis-acting elements have also been found to be located downstream of the transcriptional initiation site and within the body of genes. The immunoglobulin genes were the first examples of this class (for review see Atchison, 1988) and an increasing number of genes are now known to possess cis-acting elements downstream of their RNA leader sequence, including the Ubx. (Bienz et al., 1988) and yellow locus (Geyer and Corces, 1987) in Drosophila.
Troponin I (Yutzey et al., 1989) , a2(I) collagen (Rossi and de Crombrugghe, 1987) , aI(I) collagen (Bornstein et al., 1988) , yeast PGK (Mellor et al., 1987) , 4F2HC (Gottesdiener et al., 1988) , ADA (Aronow et al., 1989) and rat II collagen (Horton et al., 1987) are other examples of RNA pol.II transcribed genes which contain activating regulatory sequences within the body of the gene. In Thy-I all the control elements appear to be located downstream of the cap site. This is best illustrated by H2-Thyl (Fig. 3) which is transcribed from a minimal (100 bp) H2-kb promoter and shows an expression pattern identical to that of the intact Thy-I gene. Consequently, Thy-I could be one of the very rare genes identified so far (Georgopoulos et al., 1988; Basler et al., 1989; Clevers et al., 1989) with tissuespecific control elements located only downstream to promoter elements, although our experiments did not test specifically for regulatory sequences in the 5' flanking sequences. Such experiments, which are made difficult to interpret due to position effects, are in progress. Although promoter analysis has shown that certain sequences within the -100 to + 10 region are required for full activity (Spanopoulou et al., unpublished) , we cannot completely dismiss the possibility of tissue-specific control elements within the 270bp promoter fragment represented in the 5' A construct (Figure 1) . Clearly, tissue-specific control elements are present in promoters of other genes that, like Thy-1, have no TATA box and are present in GC rich hypomethylated sequences, e.g. the human HMG CoA gene (Luskey, 1987) and the human 4F2 heavy chain gene (Gottesdiener et al., 1988) . A different question relates to the suppression of Thy-1 expression in the negative tissues. This could be the result of a repressor function or the absence of activating factors. Elimination of different Thy-1 sequences [a strategy that sometimes has succeeded in identifying repressor sequences, as in the case of the human retinol binding protein gene (Colantuoni et al., 1987) ] did not result in a reproducible gain of expression in the nonexpressing tissues (liver, spleen and, in the case of H2-Thyl, also heart).
Brain expression
Analysis of the expression of deleted Thy-1 genes showed that the second half of intron 1 is required for expression in brain (this paper and Chen et al., 1987) . However, the mechanism by which this element works is unclear. When cloned upstream of a Thy-1 gene lacking that sequence (PN-AIVS1,2, Figure 1 ), or upstream of a f-globin gene (Figure 3) , it was inactive in brain. Run-on analysis showed that the very low levels of transcripts are not a consequence of cytoplasmic instability of the RNAs or of the absence of sequences which would stabilize the nuclear hnRNA. The results rather suggest a transcriptional role for that element, similar to an element identified in the first intron of the mouse ribosomal protein gene rpl32 (Chung and Perry, 1989) , of a I(I) collagen (Bornstein et al., 1988) and also that of the human f3-globin gene (Collis et al., 1989) . Deletion of these Thy-I intron sequences has no effect on thymus expression which suggests a tissue-specific role for that element, rather than the general one deduced for introns in the expression of transgenes (Brinster et al., 1988) . Furthermore, insertion of a 4.8kb genomic fragment of the c-myc gene (Figure 3) between the promoter and the brain element diminishes the expression in the brain but not thymus, indicating that the brain element is very sensitive to distance effects.
An alternative explanation for these results might be that we have discovered an element which is necessary, but not sufficient, for brain expression. (The analysis of our data leaves room for species specific complementary elements only in the 3' end of the gene). This was shown to be the case for the Drosophila dopa decarboxylase gene (Ddc) (Johnson et al., 1989) . Whatever the mechanism, the brain element(s) is able to activate heterologous promoters in a developmental specific manner (H2-Thyl and NF-L-Thy 1).
It should be noted, that loss of expression in the AIVS 1,2 and PN -AIVS 1,2 transgenic lines (Figure 3 ) accounts for -90% of the total brain activity. This implies that the rest 10% of brain activity could reflect the expression of the transgene in certain neuronal subtypes. Since immunohistochemistry was not performed on these lines, the type of cells still expressing the transgene have not been defined, but it leaves the interesting possibility that neuronal expression might be influenced by more than one transcriptional element.
Lymphoid expression of Thy-1 Our experiments clearly demonstrate the presence of an enhancer in the third intron of the murine Thy-1 gene responsible for expression in the thymus. This enhancer is able to stimulate T cell restricted transcription in a distanceand orientation-independent manner and can activate heterologous promoters (H2, olfactory marker protein gene, neurofilament light chain, ,B-globin). However, unlike other enhancers of T cell specific genes, TCRf (Krimpenfort et al., 1988) , TCRa locus (Winoto and Baltimore, 1989) , CD2 (Greaves et al., 1989 ), CD3-6 (Georgopoulos et al., 1988) or CD3-e (Clevers et al., 1989) , it is insufficient to maintain Thy-I expression in the final part of the differentiation pathway towards mature T cells. Whereas the endogenous Thy-I undergoes a down-regulation ( -25 % on T cells compared to thymocytes), the transgene is only expressed in part of thymocytes in older animals and not at all in peripheral T cells (Kollias et al., 1987a and this paper) . This suggests that mature T cells use a different regulatory mechanism to control Thy-I expression. The simplest model would imply the inactivation or absence of a thymic factor(s) interacting with the enhancer in intron 3 and new (or already present factors) may then bind to a separate (as yet unknown) control element for expression in T cells. The microinjection of a cosmid clone with -30 kb of 5' flanking sequences failed to express in splenic T cells (data not shown), which would point to the 3' end of the gene as a candidate region for the putative Thy-I T cell element. Work is in progress to identify these sequences and ultimately to understand which factors modulate expression in the differentiation of the lymphoid system.
Materials and methods

Materials
Restriction enzymes, T4 DNA ligase, reverse transcriptase, T4 polynucleotide kinase, proteinase K, SI nuclease and T7 polymerase, were purchased from Boehringer, New England Biolabs and Anglian Biotechnology. Nitrocellulose filters were from Schleicher & Schuell.
Construction of transgenes Construction of the mouse -human hybrid series was performed by employing the available common restriction sites to exchange the homologous parts of the two genes. Restriction fragments used are described in Figure  1 . The AIVSi ,2 deletion mutant was prepared by replacing the BstEl 2.7kb genomic fragment of the mh hybrid with a 135 bp BstEII cDNA fragment derived from the corresponding mouse Thy-I cDNA (Ingraham and Evans, 1986 In PN-AIVS1,2 the NruI-PvuHl 1.3 kb fragment derived from mouse Thy-I first intron was inserted in the BamHI site of the polylinker (in front of the 5' EcoRI site) as a BamHI fragment after the addition of BamHI linkers. Construction strategy followed for the rest of the constructs is described in the corresponding figure legends.
DNA fragment preparation, microinjection and analysis of transgenic animals DNA fragments were isolated free of vector sequences from a low-melting agarose gel (SeaPlaque) after phenol extraction. Fertilized oocytes from (CBA xC57-BL/lO)F1 mice were isolated, and pronuclei were injected as described previously (Kollias et al., 1987a) . Transgenic mice were identified by Southern blot analysis of 10 jg of genomic DNA (Kollias et al., 1987a) .
Tissues from mice were homogenized in 3 M LiCl -6 M Urea and RNA was isolated according to Auffray and Rougeon (1980) . Total RNA was analysed by SI protection analysis or RNase protection assays as described previously (Spanopoulou et al., 1988 (Spanopoulou et al., , 1989 . Probes were labelled with either T4 polynucleotide kinase or reverse transcriptase and restriction fragments used as probes are described in the corresponding figure legends. Conditions for run-on transcription reactions were indentical to those described previously (Spanopoulou et al., 1988) . However, hybridization was now performed at 42°C for 36 h in a hybridization buffer containing: 50% formamide, 5 xSSC, 2 xDenhardts, 2 mM sodium phosphate, 0.2% SDS, 250 Ag/ml salmon sperm DNA, 10 jtg/mil polyA,polyC and 10 pg/ml mouse genomic DNA. Immunohistochemistry, radioimmunoassay and FACS analysis were done as previously described (Kollias et al., 1987a) .
